title: [Patients with secondary open-angle glaucoma in pseudoexfoliation (PEX) syndrome among a population with high prevalence of PEX. Clinical findings and morphological and surgical characteristics].
abstract: BACKGROUND
  The second most frequent treatable cause of noninfectious blindness in Oman is high-pressure glaucoma. Therefore, in 2002 a study was performed at our department of ophthalmology to evaluate pseudoexfoliation (PEX) in glaucoma patients.
  
  
  METHODS
  In a prospective comparative cohort study, of 204 glaucoma eyes, 135 open-angle glaucomas were evaluated by biomicroscopy, papillometry, and electron microscopy and followed up after 6 months.
  
  
  RESULTS
  The incidence of PEX glaucomas relative to all glaucomas was 50.9% and to open-angle glaucomas 77%. The IOP level in PEX was higher than in POAG; the CDR, neuroretinal rim zone, and the visual field loss were not significantly different. In 38 of 104 operated PEX glaucoma eyes, the postoperative visual acuity deteriorated although the IOP was controlled.
  
  
  CONCLUSIONS
  PEX high-pressure glaucomas account for half of all glaucomas in the eastern region of the Arabian peninsula. Surgical outcomes feature a high percentage of postoperative reduction of vision in the late PEX stage.
authors.affiliation: Department of Ophthalmology and School of Ophthalmic Technicians, Sultan Qaboos University College of Medicine and Health Sciences, Muscat, Oman. alexander@squ.edu.om
authors.forename: A A
authors.initials: AA
authors.lastname: Bialasiewicz
authors.forename: U
authors.initials: U
authors.lastname: Wali
authors.forename: R
authors.initials: R
authors.lastname: Shenoy
authors.forename: R
authors.initials: R
authors.lastname: Al-Saeidi
mesh_terms: D002387:Cataract Extraction / Q000706:statistics & numerical data*; D015897:Comorbidity; D017889:Exfoliation Syndrome / Q000175:diagnosis / Q000453:epidemiology* / Q000601:surgery*; D005260:Female; D005902:Glaucoma, Open-Angle / Q000175:diagnosis / Q000453:epidemiology* / Q000601:surgery*; D006801:Humans; D008297:Male; D009850:Oman / Q000453:epidemiology; D011379:Prognosis; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors; D016896:Treatment Outcome; D014786:Vision Disorders / Q000175:diagnosis / Q000517:prevention & control